Yongzhi Wang
169 Donghu Road
Wuhan, 430071, China
Wuhan, 430071, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
BMP5 suppresses malignant progression of clear cell renal cell carcinoma by promoting DNA damage accumulation and sustained DNA damage response signaling.
Journal: Cellular signalling
Published: January 08, 2026
A case of de novo neuroendocrine prostate cancer presented with elevated level of serum CEA carrying BRCA2 mutation: case report and literature review.
Journal: Frontiers in oncology
Published: October 09, 2024
Cases of consecutive ductal adenocarcinoma of the prostate carrying HRR mutation: case series and literature review.
Journal: Oxford medical case reports
Published: January 08, 2024
DNA polymerase POLD1 promotes proliferation and metastasis of bladder cancer by stabilizing MYC.
Journal: Nature communications
Published: April 06, 2022
Erratum: RNA interference-mediated depletion of TRPM8 enhances the efficacy of epirubicin chemotherapy in prostate cancer LNCaP and PC3 cells.
Journal: Oncology letters
Published: February 14, 2022
A Gleason score-related outcome model for human prostate cancer: a comprehensive study based on weighted gene co-expression network analysis.
Journal: Cancer cell international
Published: January 10, 2020
Expression of TRPC5 is decreased in the sperm of patients with varicocele-associated asthenozoospermia.
Journal: Biomedical reports
Published: November 02, 2017
Co-expression network analysis identified FCER1G in association with progression and prognosis in human clear cell renal cell carcinoma.
Journal: International journal of biological sciences
Published: June 28, 2017
Downregulation of LAPTM5 suppresses cell proliferation and viability inducing cell cycle arrest at G0/G1 phase of bladder cancer cells.
Journal: International journal of oncology
Published: September 26, 2016
RNA interference-mediated depletion of TRPM8 enhances the efficacy of epirubicin chemotherapy in prostate cancer LNCaP and PC3 cells.
Journal: Oncology letters
Published: August 30, 2016
Last Updated: 09/26/2026